分组1 - 公司在心力衰竭业务实现21%的收入增长,这是连续两个季度的强劲增长,归因于积极的同行评审发表和临床证据的支持 [12][13] - 公司致力于在住院周期的更早阶段推广超滤治疗,并在多个医院专科部门推广使用 [14][15] - 公司在儿科业务方面保持乐观,预计将于2024年第一季度获得新型儿科专用连续性肾脏替代治疗设备的IDE批准 [16][17][29] - 公司正在拓展Aquadex超滤系统在其他适应症的应用,如肝病和左心室辅助设备植入患者 [18][57] 分组2 - 公司发表了一篇同行评审文章,支持使用超滤治疗对利尿剂无效的心力衰竭患者 [21][25][26] - 公司的"逆转心力衰竭"临床试验目前已有11个激活的试验点,患者入组数翻倍 [27][28] - 公司的儿科专用连续性肾脏替代治疗设备研发进展顺利,预计2024年第一季度获得IDE批准 [29][30] - 公司正在通过临床数据提高医生和医疗机构对Aquadex超滤系统的认知,推动在多个专科部门和门诊中心的应用 [31][32] 问答环节重要的提问和回答 问题1 **Jeffrey Cohen 提问** 儿科业务收入下滑的原因是什么,儿科业务占总收入的比重是多少? [45][46][47] **Nestor Jaramillo 和 Lynn Blake 回答** 主要是由于公司主要的儿科账户患者入院人数下降,儿科业务占Q1总收入的23% [46][47] 问题2 **Jeffrey Cohen 提问** 公司对心力衰竭业务在今年剩余时间的预期是什么? [54][55] **Nestor Jaramillo 回答** 公司预计心力衰竭业务收入将继续实现双位数增长,并将继续利用临床数据提高医生的认知 [55] 问题3 **Anthony Vendetti 提问** 公司如何向医院推广Aquadex超滤系统,主要针对哪些人群和科室? [63][64][66][67] **Nestor Jaramillo、John Kowalczyk 和 John Jefferies 回答** 公司的推广策略是向医生和医院管理层双管齐下,提供临床数据支持,并针对不同科室如心力衰竭、肝病、LVAD等推广使用 [64][66][67][72][73]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-35312 NUWELLIS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware No. 68-0533453 (State or Other J ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 001-35312 NUWELLIS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0533453 (State or other jurisdiction of incorp oration or ...

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President and CEO Lynn Blake - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Anthony Vendetti - Maxim Group Brooks O'Neil - Lake Street Capital Markets Operator Good morning, and welcome to the Nuwellis Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded. Now ...

Nuwellis, Inc. (NASDAQ:NUWE) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President & Chief Executive Officer Lynn Blake - CFO Conference Call Participants Jeff Cohen - Ladenburg Thalmann Charlie Montang - Lake Street Capital Markets Operator Good day and welcome to the Nuwellis Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised today's conference is being recorded. I would now like to turn the ...

Nuwellis, Inc. (NASDAQ:NUWE) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Matthew Bacso - Gilmartin Group LLC George Montague - Chief Financial Officer Nestor Jaramillo - President & Chief Executive Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Brooks O'Neil - Lake Street Capital Markets Anthony Vendetti - Maxim Group Operator Good day and thank you for standing by. Welcome to the Nuwellis, Inc. Second Quarter 2022 Earnings Conference Call. [Operator ...

Restoring Fluid Baland Corporate Presentation (Nasdaq: NUWE) May 2022 FOR INVESTOR PURPOSES ONLY: NOT FOR PRODUCT PROMOTION ©2022 Nuwellis, Inc. Safe Harbor Statement FOR INVESTOR PURPOSES ONLY: NOT FOR PRODUCT PROMOTION ©2022 Nuwellis, Inc. 2 2 Forward Looking Statement This presentation contains forward‐looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act, as amended regarding our plans, expectations, beliefs, est ...

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2022 Earnings Conference Call May 10, 2022 9:00 AM ET Company Participants Matthew Bacso - Gilmartin Group Nestor Jaramillo - President, CEO & Director George Montague - CFO Conference Call Participants Destiny Buch - Ladenburg Thalmann & Co. Anthony Vendetti - Maxim Group Operator Good day and thank you for standing by. Welcome to the Nuwellis, Inc. First Quarter 2022 Earnings. [Operator Instructions]. I would now like to hand a conference over to Matt Bacso. Please go ahead ...

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2021 Earnings Conference Call March 1, 2022 9:00 AM ET Company Participants Matt Bacso ??? Investor Relations Nestor Jaramillo ??? President and Chief Executive Officer George Montague ??? Chief Financial Officer Conference Call Participants Jeffrey Cohen ??? Ladenburg Thalmann Brooks O???Neil ??? Lake Street Capital Markets Matt Bullock ??? Maxim Group Operator Good day and welcome to the Nuwellis Inc Fourth Quarter 2021 Earnings Call. At this time, all participants are in a ...

Nuwellis, Inc. (NASDAQ:NUWE) Q3 2021 Earnings Conference Call November 9, 2021 9:00 AM ET Company Participants Matt Beckel - Gilmartin Group Nestor Jaramillo - President & CEO George Montague - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Brooks O'Neil - Lake Street Capital Markets Anthony Vendetti - Maxim Group Operator Good day and thank you for standing by. Welcome to the Nuwellis, Inc. Third quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only ...